SATVI author, Associate Professor Tom Scriba has co-authored a paper titled "Safety and Immunogenicity of Adenovirus 35 TB Vaccine Candidate in Adults with Active or Previous TB: a Randomized Trial" appearing in the American Journal of Respiratory and Critical Care Medicine.
SATVI authors Dr Adam Penn-Nicholson, Associate Professor Tom Scriba and Professor Mark Hatherill have published a paper titled "A novel blood test for tuberculosis prevention and treatment" appearing in the January edition of the South African Medical Journal.
Dr Sara Suliman, Postdoctoral Fellow has departed from SATVI to take up a postdoctoral fellowship at the Brigham and Women's Hospital at Harvard Medical School.
We invite applications from suitably qualified candidates for a vacancy as Senior Scientific Officer in the Immunology Laboratory of the South African Tuberculosis Vaccine Initiative. Closing Date 27 January 2017.